These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 28107816
1. The time course of erythrocyte membrane fatty acid concentrations during and after treatment of non-human primates with increasing doses of an omega-3 rich phospholipid preparation derived from krill-oil. Hals PA, Wang X, Piscitelli F, Di Marzo V, Xiao YF. Lipids Health Dis; 2017 Jan 21; 16(1):16. PubMed ID: 28107816 [Abstract] [Full Text] [Related]
2. Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia. Hals PA, Wang X, Xiao YF. Lipids Health Dis; 2017 Jan 17; 16(1):11. PubMed ID: 28095913 [Abstract] [Full Text] [Related]
3. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hänninen O, Uusitupa MI. Lipids; 1997 Jul 17; 32(7):697-705. PubMed ID: 9252957 [Abstract] [Full Text] [Related]
4. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Yurko-Mauro K, Kralovec J, Bailey-Hall E, Smeberg V, Stark JG, Salem N. Lipids Health Dis; 2015 Sep 02; 14():99. PubMed ID: 26328782 [Abstract] [Full Text] [Related]
5. Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study. Berge RK, Ramsvik MS, Bohov P, Svardal A, Nordrehaug JE, Rostrup E, Bruheim I, Bjørndal B. Lipids Health Dis; 2015 Dec 15; 14():163. PubMed ID: 26666303 [Abstract] [Full Text] [Related]
6. Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trial. Köhler A, Sarkkinen E, Tapola N, Niskanen T, Bruheim I. Lipids Health Dis; 2015 Mar 15; 14():19. PubMed ID: 25884846 [Abstract] [Full Text] [Related]
7. Acute appearance of fatty acids in human plasma--a comparative study between polar-lipid rich oil from the microalgae Nannochloropsis oculata and krill oil in healthy young males. Kagan ML, West AL, Zante C, Calder PC. Lipids Health Dis; 2013 Jul 15; 12():102. PubMed ID: 23855409 [Abstract] [Full Text] [Related]
8. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Clin Chem; 2006 Dec 15; 52(12):2265-72. PubMed ID: 17053155 [Abstract] [Full Text] [Related]
9. Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Ramprasath VR, Eyal I, Zchut S, Jones PJ. Lipids Health Dis; 2013 Dec 05; 12():178. PubMed ID: 24304605 [Abstract] [Full Text] [Related]
10. Comparative study of tissue deposition of omega-3 fatty acids from polar-lipid rich oil of the microalgae Nannochloropsis oculata with krill oil in rats. Kagan ML, Levy A, Leikin-Frenkel A. Food Funct; 2015 Jan 05; 6(1):186-92. PubMed ID: 25360534 [Abstract] [Full Text] [Related]
11. Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil. Ramprasath VR, Eyal I, Zchut S, Shafat I, Jones PJ. Lipids Health Dis; 2015 Nov 04; 14():142. PubMed ID: 26537218 [Abstract] [Full Text] [Related]
12. Metabolic fate (absorption, β-oxidation and deposition) of long-chain n-3 fatty acids is affected by sex and by the oil source (krill oil or fish oil) in the rat. Ghasemifard S, Hermon K, Turchini GM, Sinclair AJ. Br J Nutr; 2015 Sep 14; 114(5):684-92. PubMed ID: 26234617 [Abstract] [Full Text] [Related]
13. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil. Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A. Lipids Health Dis; 2011 Aug 22; 10():145. PubMed ID: 21854650 [Abstract] [Full Text] [Related]
14. Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse. Wang S, Wu D, Matthan NR, Lamon-Fava S, Lecker JL, Lichtenstein AH. Atherosclerosis; 2009 May 22; 204(1):147-55. PubMed ID: 18842266 [Abstract] [Full Text] [Related]
15. n-3 polyunsaturated fatty acids in phospholipid or triacylglycerol form attenuate nonalcoholic fatty liver disease via mediating cannabinoid receptor 1/adiponectin/ceramide pathway. Chen YF, Fan ZK, Gao X, Zhou F, Guo XF, Sinclair AJ, Li D. J Nutr Biochem; 2024 Jan 22; 123():109484. PubMed ID: 37866428 [Abstract] [Full Text] [Related]
16. Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women. Ras RT, Demonty I, Zebregs YE, Quadt JF, Olsson J, Trautwein EA. J Nutr; 2014 Oct 22; 144(10):1564-70. PubMed ID: 25122648 [Abstract] [Full Text] [Related]
17. Associations between dietary n-6 and n-3 fatty acids and arachidonic acid compositions in plasma and erythrocytes in young and elderly Japanese volunteers. Kawabata T, Hirota S, Hirayama T, Adachi N, Kaneko Y, Iwama N, Kamachi K, Araki E, Kawashima H, Kiso Y. Lipids Health Dis; 2011 Aug 13; 10():138. PubMed ID: 21838914 [Abstract] [Full Text] [Related]
18. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels. Berge K, Musa-Veloso K, Harwood M, Hoem N, Burri L. Nutr Res; 2014 Feb 13; 34(2):126-33. PubMed ID: 24461313 [Abstract] [Full Text] [Related]
19. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ. Am J Clin Nutr; 2000 May 13; 71(5):1085-94. PubMed ID: 10799369 [Abstract] [Full Text] [Related]
20. Accretion of Dietary Docosahexaenoic Acid in Mouse Tissues Did Not Differ between Its Purified Phospholipid and Triacylglycerol Forms. Adkins Y, Laugero KD, Mackey B, Kelley DS. Lipids; 2019 Jan 13; 54(1):25-37. PubMed ID: 30697752 [Abstract] [Full Text] [Related] Page: [Next] [New Search]